AU673754B2 - Tetrazole derivatives having antihistaminic and antiallergic activity - Google Patents

Tetrazole derivatives having antihistaminic and antiallergic activity Download PDF

Info

Publication number
AU673754B2
AU673754B2 AU69830/94A AU6983094A AU673754B2 AU 673754 B2 AU673754 B2 AU 673754B2 AU 69830/94 A AU69830/94 A AU 69830/94A AU 6983094 A AU6983094 A AU 6983094A AU 673754 B2 AU673754 B2 AU 673754B2
Authority
AU
Australia
Prior art keywords
document
atom
compound
cited
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU69830/94A
Other languages
English (en)
Other versions
AU6983094A (en
Inventor
Masatoshi Hayashi
Masaya Kato
Kazuhiko Mitsui
Yusuke Sakai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Steel Corp
Original Assignee
Sumitomo Metal Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Metal Industries Ltd filed Critical Sumitomo Metal Industries Ltd
Publication of AU6983094A publication Critical patent/AU6983094A/en
Application granted granted Critical
Publication of AU673754B2 publication Critical patent/AU673754B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU69830/94A 1993-06-29 1994-06-23 Tetrazole derivatives having antihistaminic and antiallergic activity Expired - Fee Related AU673754B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP15874193 1993-06-29
JP5-158741 1993-06-29
JP15874593 1993-06-29
JP5-158745 1993-06-29
JP13875694A JP3338913B2 (ja) 1993-06-29 1994-06-21 テトラゾール誘導体
JP6-138756 1994-06-21
PCT/JP1994/001010 WO1995001350A1 (en) 1993-06-29 1994-06-23 Tetrazole derivatives having antihistaminic and antiallergic activity

Publications (2)

Publication Number Publication Date
AU6983094A AU6983094A (en) 1995-01-24
AU673754B2 true AU673754B2 (en) 1996-11-21

Family

ID=27317735

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69830/94A Expired - Fee Related AU673754B2 (en) 1993-06-29 1994-06-23 Tetrazole derivatives having antihistaminic and antiallergic activity

Country Status (8)

Country Link
EP (1) EP0706522A1 (enExample)
JP (1) JP3338913B2 (enExample)
KR (1) KR960703405A (enExample)
AU (1) AU673754B2 (enExample)
CA (1) CA2165792A1 (enExample)
IL (1) IL110144A0 (enExample)
TW (1) TW281677B (enExample)
WO (1) WO1995001350A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3779349B2 (ja) * 1995-04-24 2006-05-24 興和株式会社 ピペリジン誘導体
EP0916668A4 (en) * 1996-07-29 2000-08-16 Banyu Pharma Co Ltd CHEMOKIN RECEPTOR ANTAGONISTS
ES2172436B1 (es) * 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
WO2003032912A2 (en) 2001-10-16 2003-04-24 Hypnion, Inc. Treatment of cns disorders using cns target modulators
US7355042B2 (en) 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
US7189757B2 (en) 2001-10-16 2007-03-13 Hypnion, Inc. Treatment of sleep disorders using CNS target modulators
ES2201907B1 (es) 2002-05-29 2005-06-01 Almirall Prodesfarma, S.A. Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
AU2003296373A1 (en) * 2002-12-18 2004-07-29 Bayer Cropscience Ag N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
US7326721B2 (en) 2003-12-10 2008-02-05 Hypnion, Inc. Doxepin analogs and methods of use thereof
US7411069B2 (en) 2003-12-10 2008-08-12 Hypnion, Inc. Doxepin analogs and methods of use thereof
US7482460B2 (en) 2003-12-10 2009-01-27 Hypnion, Inc. Doxepin analogs and methods of use thereof
WO2005102335A2 (en) * 2004-04-23 2005-11-03 Hypnion, Inc. Methods of treating sleep disorders
US20080214570A1 (en) * 2005-08-08 2008-09-04 Astrazeneca Ab Therapeutic Agents
WO2010013805A1 (ja) * 2008-08-01 2010-02-04 日本臓器製薬株式会社 アミノプロピリデン誘導体
JP7040802B2 (ja) * 2017-06-30 2022-03-23 株式会社ニコン 光学装置を製造する方法及び対応するシステム
JP6991315B2 (ja) 2018-04-19 2022-01-12 国立大学法人東京農工大学 サルコペニアの予防剤及び治療剤
CN113880808B (zh) * 2020-07-03 2024-12-31 合肥医工医药股份有限公司 一类三唑类化合物、制备方法及其医药用途
EP4691466A1 (en) 2023-07-25 2026-02-11 The Eye Hospital of Wenzhou Medical University Use of ptgds inhibitor in preparation of drug for treating cataracts
CN117599052A (zh) * 2023-07-25 2024-02-27 温州医科大学附属眼视光医院 Ptgds的抑制剂在制备治疗白内障药物上的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8023182A (en) * 1981-02-06 1982-08-12 Ucb 2-(4-(diphenylmethyl)-1-piperazinyl)-acetic acids and their amides
AU8127991A (en) * 1990-07-26 1992-02-06 Laboratorios Del Dr. Esteve, S.A. Novel derivatives of 1-diphenylmethyl piperazine, their preparation and their use as medicaments

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03246287A (ja) * 1990-02-22 1991-11-01 Hokuriku Seiyaku Co Ltd ピペラジン誘導体
FR2665161B1 (fr) * 1990-07-26 1992-11-27 Esteve Labor Dr Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8023182A (en) * 1981-02-06 1982-08-12 Ucb 2-(4-(diphenylmethyl)-1-piperazinyl)-acetic acids and their amides
AU8127991A (en) * 1990-07-26 1992-02-06 Laboratorios Del Dr. Esteve, S.A. Novel derivatives of 1-diphenylmethyl piperazine, their preparation and their use as medicaments

Also Published As

Publication number Publication date
CA2165792A1 (en) 1995-01-12
JPH0770112A (ja) 1995-03-14
KR960703405A (ko) 1996-08-17
JP3338913B2 (ja) 2002-10-28
AU6983094A (en) 1995-01-24
IL110144A0 (en) 1994-10-07
TW281677B (enExample) 1996-07-21
EP0706522A1 (en) 1996-04-17
WO1995001350A1 (en) 1995-01-12

Similar Documents

Publication Publication Date Title
AU673754B2 (en) Tetrazole derivatives having antihistaminic and antiallergic activity
EP0100200B1 (en) 2-substituted 4-amino-6,7-dimethoxyquinolines
DE69008012T2 (de) 4-Fluorbenzolderivate, Herstellungsverfahren und diese enthaltende pharmazeutische Zusammensetzungen.
DE69330823T2 (de) Thiacyclische piperidinylderivate
EP0277794B1 (en) N-heterocyclic-N-(4-piperidyl) amides
US4680296A (en) Piperidine derivatives and pharmaceutical compositions containing them
HU211144A9 (en) Cyclic amine derivatives and their pharmaceutical use
CA1072562A (en) 1-substituted-4-benzylidenepiperidines
PL192397B1 (pl) Pochodna 1-(1,2-dipodstawionej piperydynylo)-4-piperydyny, jej zastosowanie, sposób wytwarzania i kompozycja farmaceutyczna
DD300434A5 (de) Heterozyklische derivate
CH663022A5 (de) 1-fluorphenylbutyl-4-(2-pyrimidinyl)piperazin-derivate mit antipsychotischer aktivitaet.
CA2045453C (en) Condensed heterocyclic compound and psychopharmaceutical composition containing same
AU594972B2 (en) N-substituted-arylalkyl and arylalkylene aminoheterocyclics as cardiovascular antihistaminic and antisecretory agents
DE2939292A1 (de) N-phenoxyalkylpiperidin-derivate, verfahrenn zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
EP0399414B1 (en) Piperidine derivative, method for preparation thereof, and a pharmaceutical composition comprising the same
US5095022A (en) Piperidine derivatives and pharmaceutical compositions comprising the same
DE69007126T2 (de) Muscarin-rezeptor-antagonisten.
US6518282B1 (en) 4-Arylpiperidine derivatives for the treatment of pruritus
US5486527A (en) Anticholinergic agents
DD228547A5 (de) Verfahren zur herstellung von neuen amid-verbindungen
DE69013173T2 (de) Bisarylalkenderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzung, die sie enthalten.
EP1072594A2 (en) 4-arylpiperidine derivatives for the treatment of pruritus
EP0506903A1 (en) 4-acetoxy-piperidine derivatives, process for their preparation and use as a muscarinic m3-receptor antagonist
DE69014903T2 (de) Disubstituierte piperidine und pyrrolidine als anticholinergische mittel.
EP0913393B1 (en) Arylacetic amide derivative or salt thereof, and pharmaceutical comprising it